https://sciex.com/content/SCIEX/na/us/en

AB Sciex is doing business as SCIEX. © 2010-2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license. Beckman Coulter® is being used under license. Product(s) may not be available in all countries. For information on availability, please contact your local representative. For research use only. Not for use in diagnostic procedures.

<a href="https://community.sciex.com/author/commmunitysuperuser/" target="_self">SCIEX Community</a>

SCIEX Community

Facebook
X (Twitter)
LinkedIn
Share


The SCIEX Software Roadmap – The Journey Towards Windows 10 Compatibility is Complete

Feb 22, 2019 | Blogs, Software, Technology | 0 comments

At SCIEX we are committed to providing you with the most up-to-date tools and technologies to meet the evolving needs of the laboratory. As part of that commitment, we were introducing our software product roadmap towards Windows 10 compatibility back in 2017. Many of you are making long-term investments in SCIEX technologies, and we recognize how important it is for you to have visibility of new features coming down the road. As of February 2019, we can proudly announce that our complete suite of software solutions supports the Microsoft Windows 10 operating system (OS). 

Our internal roadmap is a living document – it changes weekly to adapt quickly, respond to demand, capture opportunities, and optimize resources.  While this roadmap was subject to change and we were not able to provide exact estimates or timelines on feature releases we hope it helped provide some insight into when individual SCIEX applications were made available on Windows 10.

Future-Proof Your System by Moving to Windows 10
Presumably, you are aware that as of January 14, 2020, Microsoft will no longer support the Windows 7 OS. Therefore, your organization may already have started or completed the migration process to Windows 10, securing that you will receive continued support from Microsoft, 64-bit computing capabilities, and the peace of mind that comes with working in a more secure lab environment.

As your laboratory moves on to Windows 10, you will be required to purchase new acquisition PCs for instrument control. Since we do not want your computer to hold you back, SCIEX has created a solution for a seamless upgrade, the new SCIEX Alpha Workstation 2020 has just launched. Find out more about the benefits of getting up to speed with an upgrade to Windows 10 and to take advantage of our special upgrade programs. 

Upgrading Analyst® Software for Compatibility with Windows 10  
As always, our roadmap is completely defined by building the best product we can for you.  Contact us anytime, if you have questions about the Windows 10 upgrade path or want to learn how to increase your lab’s productivity with our Windows 10 compatible software suite.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Supporting new CRISPR gene editing systems

Prime editing (PE) is a next-generation gene editing technology that utilizes a Cas9 protein fused to a prime editing guide ribonucleic acid (pegRNA) to achieve high CRISPR/Cas9 editing efficiency and precision. However, the length requirement of pegRNAs at 120–250 nucleotides (nt) and their high level of secondary structure formation present analytical challenges for the purity analysis of chemically synthesized pegRNAs during development and quality control (QC).

A new approach for comprehensive AAV evaluation including full and empty analysis

Certain next-gen vaccines and gene therapy applications rely on the usage of adeno-associated viruses (AAV) as a delivery vehicle. To ensure the safety and efficacy of viral vector drugs, multiple critical quality attributes (CQAs) need to be well characterized.

Posted by

Community Manager
Tags
biotherapeutic developmentblazechargecompanycoupledevelopmentjobmachinemassmoneynewnumberpowerproteinrapidSCIEX OS Softwaresystemtechnologytimevariantwork

0 Comments

Submit a Comment

SCIEX Now™ Support Network

The Destination for All Your Support Needs

The SCIEX clinical diagnostic portfolio is For In Vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures. Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks).

Echo and Echo MS are trademarks or registered trademarks of Labcyte, Inc. in the United States and other countries, and are being used under license.
Empower is a trademark of Waters Corporation used under license. © DH Tech. Dev. Pte. Ltd.

Wordpress Social Share Plugin powered by Ultimatelysocial